331 related articles for article (PubMed ID: 15286393)
1. Proteoglycan aggrecan-induced arthritis: a murine autoimmune model of rheumatoid arthritis.
Glant TT; Mikecz K
Methods Mol Med; 2004; 102():313-38. PubMed ID: 15286393
[TBL] [Abstract][Full Text] [Related]
2. Progressive polyarthritis induced in BALB/c mice by aggrecan from normal and osteoarthritic human cartilage.
Glant TT; Cs-Szabó G; Nagase H; Jacobs JJ; Mikecz K
Arthritis Rheum; 1998 Jun; 41(6):1007-18. PubMed ID: 9627010
[TBL] [Abstract][Full Text] [Related]
3. Critical roles of glycosaminoglycan side chains of cartilage proteoglycan (aggrecan) in antigen recognition and presentation.
Glant TT; Buzás EI; Finnegan A; Negroiu G; Cs-Szabó G; Mikecz K
J Immunol; 1998 Apr; 160(8):3812-9. PubMed ID: 9558085
[TBL] [Abstract][Full Text] [Related]
4. Increased arthritis susceptibility in cartilage proteoglycan-specific T cell receptor-transgenic mice.
Berlo SE; Guichelaar T; Ten Brink CB; van Kooten PJ; Hauet-Broeren F; Ludanyi K; van Eden W; Broeren CP; Glant TT
Arthritis Rheum; 2006 Aug; 54(8):2423-33. PubMed ID: 16869010
[TBL] [Abstract][Full Text] [Related]
5. Induction of arthritis in SCID mice by T cells specific for the "shared epitope" sequence in the G3 domain of human cartilage proteoglycan.
Hanyecz A; Bárdos T; Berlo SE; Buzás E; Nesterovitch AB; Mikecz K; Glant TT
Arthritis Rheum; 2003 Oct; 48(10):2959-73. PubMed ID: 14558103
[TBL] [Abstract][Full Text] [Related]
6. Proteoglycan (aggrecan)-induced arthritis in BALB/c mice is a Th1-type disease regulated by Th2 cytokines.
Finnegan A; Mikecz K; Tao P; Glant TT
J Immunol; 1999 Nov; 163(10):5383-90. PubMed ID: 10553063
[TBL] [Abstract][Full Text] [Related]
7. T-cell recognition of differentially tolerated epitopes of cartilage proteoglycan aggrecan in arthritis.
Buzás EI; Végvári A; Murad YM; Finnegan A; Mikecz K; Glant TT
Cell Immunol; 2005 Jun; 235(2):98-108. PubMed ID: 16185673
[TBL] [Abstract][Full Text] [Related]
8. Achievement of a synergistic adjuvant effect on arthritis induction by activation of innate immunity and forcing the immune response toward the Th1 phenotype.
Hanyecz A; Berlo SE; Szántó S; Broeren CP; Mikecz K; Glant TT
Arthritis Rheum; 2004 May; 50(5):1665-76. PubMed ID: 15146438
[TBL] [Abstract][Full Text] [Related]
9. Induction of arthritis in HLA-DR4-humanized and HLA-DQ8-humanized mice by human cartilage proteoglycan aggrecan but only in the presence of an appropriate (non-MHC) genetic background.
Szántó S; Bárdos T; Szabó Z; David CS; Buzás EI; Mikecz K; Glant TT
Arthritis Rheum; 2004 Jun; 50(6):1984-95. PubMed ID: 15188376
[TBL] [Abstract][Full Text] [Related]
10. Molecular manipulation with the arthritogenic epitopes of the G1 domain of human cartilage proteoglycan aggrecan.
Murad YM; Szabó Z; Ludányi K; Glant TT
Clin Exp Immunol; 2005 Nov; 142(2):303-11. PubMed ID: 16232217
[TBL] [Abstract][Full Text] [Related]
11. A proteoglycan (aggrecan)-specific T cell hybridoma induces arthritis in BALB/c mice.
Buzás EI; Brennan FR; Mikecz K; Garzó M; Negroiu G; Holló K; Cs-Szabó G; Pintye E; Glant TT
J Immunol; 1995 Sep; 155(5):2679-87. PubMed ID: 7544381
[TBL] [Abstract][Full Text] [Related]
12. Human cartilage aggrecan CS1 region contains cryptic T-cell recognition sites.
Goodacre JA; Middleton S; Lynn S; Ross DA; Pearson J
Immunology; 1993 Apr; 78(4):586-91. PubMed ID: 8388364
[TBL] [Abstract][Full Text] [Related]
13. Variations in susceptibility to proteoglycan-induced arthritis and spondylitis among C3H substrains of mice: evidence of genetically acquired resistance to autoimmune disease.
Glant TT; Bárdos T; Vermes C; Chandrasekaran R; Valdéz JC; Otto JM; Gerard D; Velins S; Lovász G; Zhang J; Mikecz K; Finnegan A
Arthritis Rheum; 2001 Mar; 44(3):682-92. PubMed ID: 11263784
[TBL] [Abstract][Full Text] [Related]
14. Continuous nasal administration of antigen is critical to maintain tolerance in adoptively transferred autoimmune arthritis in SCID mice.
Bárdos T; Czipri M; Vermes C; Zhang J; Mikecz K; Glant TT
Clin Exp Immunol; 2002 Aug; 129(2):224-31. PubMed ID: 12165077
[TBL] [Abstract][Full Text] [Related]
15. VDIPEN, a metalloproteinase-generated neoepitope, is induced and immunolocalized in articular cartilage during inflammatory arthritis.
Singer II; Kawka DW; Bayne EK; Donatelli SA; Weidner JR; Williams HR; Ayala JM; Mumford RA; Lark MW; Glant TT
J Clin Invest; 1995 May; 95(5):2178-86. PubMed ID: 7537757
[TBL] [Abstract][Full Text] [Related]
16. Complex pattern of Th1 and Th2 activation with a preferential increase of autoreactive Th1 cells in BALB/c mice with proteoglycan (aggrecan)-induced arthritis.
Holló K; Glant TT; Garzó M; Finnegan A; Mikecz K; Buzás E
Clin Exp Immunol; 2000 Apr; 120(1):167-73. PubMed ID: 10759779
[TBL] [Abstract][Full Text] [Related]
17. The mouse model of collagen-induced arthritis.
Brand DD; Kang AH; Rosloniec EF
Methods Mol Med; 2004; 102():295-312. PubMed ID: 15286392
[TBL] [Abstract][Full Text] [Related]
18. Mapping of arthritogenic/autoimmune epitopes of cartilage aggrecans in proteoglycan-induced arthritis.
Glant TT; Fülöp C; Cs-Szabó G; Buzás E; Ragasa D; Mikecz K
Scand J Rheumatol Suppl; 1995; 101():43-9. PubMed ID: 7538228
[TBL] [Abstract][Full Text] [Related]
19. Proteoglycan-induced arthritis and recombinant human proteoglycan aggrecan G1 domain-induced arthritis in BALB/c mice resembling two subtypes of rheumatoid arthritis.
Glant TT; Radacs M; Nagyeri G; Olasz K; Laszlo A; Boldizsar F; Hegyi A; Finnegan A; Mikecz K
Arthritis Rheum; 2011 May; 63(5):1312-21. PubMed ID: 21305522
[TBL] [Abstract][Full Text] [Related]
20. Cellular immunity to the G1 domain of cartilage proteoglycan aggrecan is enhanced in patients with rheumatoid arthritis but only after removal of keratan sulfate.
Guerassimov A; Zhang Y; Banerjee S; Cartman A; Leroux JY; Rosenberg LC; Esdaile J; Fitzcharles MA; Poole AR
Arthritis Rheum; 1998 Jun; 41(6):1019-25. PubMed ID: 9627011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
